Loading clinical trials...
Loading clinical trials...
A Phase 2 Study of Duvelisib in Subjects With Refractory Indolent Non-Hodgkin Lymphoma
Conditions
Interventions
Duvelisib
Locations
69
United States
Los Angeles, California, United States
Whittier, California, United States
Denver, Colorado, United States
Fort Myers, Florida, United States
St. Petersburg, Florida, United States
Tallahassee, Florida, United States
Start Date
June 17, 2013
Primary Completion Date
November 18, 2020
Completion Date
November 18, 2020
Last Updated
September 7, 2023
NCT05418088
NCT03749018
NCT03884998
NCT04464200
NCT03583424
NCT02566304
Lead Sponsor
SecuraBio
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions